Kai Huang1, Rongfa Yuan1, Kai Wang1, Junwen Hu1, Zixi Huang1, Chen Yan1, Wei Shen1, Jianghua Shao1. 1. 1 Department of General Surgery, Second Affiliated Hospital of Nanchang University, Nanchang 330006, China ; 2 Department of Gastrointestinal Surgery, Jiangxi Provincial Cancer Hospital, Nanchang 330029, China ; 3 Jiangxi Province Key Laboratory of Molecular Medicine, Nanchang 330006, China.
Abstract
OBJECTIVE: Homeobox B9 (HOXB9) is proposed to be involved in tumor angiogenesis and metastasis. We investigated the role of HOXB9 in the progression of colon cancer. METHODS: HOXB9 expression was investigated by immunohistochemically and Western blotting in 128 colon cancer patients and the results were analyzed statistically associated with clinicopathological data and survival of the patients. The effect of HOXB9 on cell invasion and metastases abilities were analyzed in vitro and in vivo. RESULTS: HOXB9 is overexpressed in colon cancer tissues and significantly correlated with metastasis and poor survival of patients (P<0.05, respectively). Additionally, high levels of expression of HOXB9 were observed in metastatic lymph nodes. The down-regulation of HOXB9 expression can inhibit the migration and invasive ability of colon cancer cells, while exogenous expression of HOXB9 in colon cancer cells enhanced cell migration and invasiveness. Moreover, stable knockdown of HOXB9 reduced the liver and lung metastasis of colon cancer in vivo. CONCLUSIONS: HOXB9 may play an important role in the invasion and metastasis of colon cancer cells and may be a useful biomarker for metastasis and prognostic of colon cancer.
OBJECTIVE: Homeobox B9 (HOXB9) is proposed to be involved in tumor angiogenesis and metastasis. We investigated the role of HOXB9 in the progression of colon cancer. METHODS:HOXB9 expression was investigated by immunohistochemically and Western blotting in 128 colon cancerpatients and the results were analyzed statistically associated with clinicopathological data and survival of the patients. The effect of HOXB9 on cell invasion and metastases abilities were analyzed in vitro and in vivo. RESULTS:HOXB9 is overexpressed in colon cancer tissues and significantly correlated with metastasis and poor survival of patients (P<0.05, respectively). Additionally, high levels of expression of HOXB9 were observed in metastatic lymph nodes. The down-regulation of HOXB9 expression can inhibit the migration and invasive ability of colon cancer cells, while exogenous expression of HOXB9 in colon cancer cells enhanced cell migration and invasiveness. Moreover, stable knockdown of HOXB9 reduced the liver and lung metastasis of colon cancer in vivo. CONCLUSIONS:HOXB9 may play an important role in the invasion and metastasis of colon cancer cells and may be a useful biomarker for metastasis and prognostic of colon cancer.
Authors: Naokazu Chiba; Valentine Comaills; Bunsyo Shiotani; Fumiyuki Takahashi; Toshiyuki Shimada; Ken Tajima; Daniel Winokur; Tetsu Hayashida; Henning Willers; Elena Brachtel; Maria D M Vivanco; Daniel A Haber; Lee Zou; Shyamala Maheswaran Journal: Proc Natl Acad Sci U S A Date: 2011-09-19 Impact factor: 11.205
Authors: R Calvo; J West; W Franklin; P Erickson; L Bemis; E Li; B Helfrich; P Bunn; J Roche; E Brambilla; R Rosell; R M Gemmill; H A Drabkin Journal: Proc Natl Acad Sci U S A Date: 2000-11-07 Impact factor: 11.205
Authors: Don X Nguyen; Anne C Chiang; Xiang H-F Zhang; Juliet Y Kim; Mark G Kris; Marc Ladanyi; William L Gerald; Joan Massagué Journal: Cell Date: 2009-07-02 Impact factor: 41.582
Authors: Sandra F Martins; Eduardo A Garcia; Marcus Alexandre Mendes Luz; Fernando Pardal; Mesquita Rodrigues; Adhemar Longatto Filho Journal: Cancer Genomics Proteomics Date: 2013 Mar-Apr Impact factor: 4.069
Authors: Benjamin L Kidder; Runsheng He; Darawalee Wangsa; Hesed M Padilla-Nash; M Margarida Bernardo; Shijie Sheng; Thomas Ried; Keji Zhao Journal: Cancer Res Date: 2017-09-26 Impact factor: 12.701
Authors: Petra Vychytilova-Faltejskova; Jana Merhautova; Tana Machackova; Irene Gutierrez-Garcia; José Garcia-Solano; Lenka Radova; Dominika Brchnelova; Katerina Slaba; Marek Svoboda; Jana Halamkova; Regina Demlova; Igor Kiss; Rostislav Vyzula; Pablo Conesa-Zamora; Ondrej Slaby Journal: Oncogenesis Date: 2017-12-04 Impact factor: 7.485
Authors: Grace Jefferies; Jason Somers; Isabelle Lohrey; Vishal Chaturvedi; Jacob Calabria; Owen J Marshall; Tony D Southall; Robert Saint; Michael J Murray Journal: G3 (Bethesda) Date: 2020-12-03 Impact factor: 3.154